
1. Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):383-393. doi:
10.1007/s10096-018-3438-9. Epub 2018 Nov 28.

Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French
case-control-control study.

Nicolas-Chanoine MH(1)(2), Vigan M(3)(4), Laouénan C(5)(3)(4), Robert J(6)(7);
“E-carb Study Group”.

Collaborators: Laurans C, Vachée A, Lemaître N, Pantel A, Lavigne JP, Cavalie L, 
Marty N, Bertrand X, De Champs C, Bajolet O, Limelette A, Corvec S, Bourigault C,
Lepelletier D, van der Mee-Marquet N, Merens A, Carbonnelle E, Billard-Pomares T,
Bert F, Leflon-Guibout V, Duprilot M, Nérome S, Cambau E, Jacquier H, Benmansour 
H, Jarlier V, Lafeuille E, Decré D.

Author information: 
(1)Service de Microbiologie, Hôpital Beaujon, AP-HP, F-92110, Clichy, France.
marie-helene.nicolas-chanoine@inserm.fr.
(2)INSERM and University Paris Diderot, IAME, UMR 1137, 16 rue Henri Huchard,
F-75018, Paris, France. marie-helene.nicolas-chanoine@inserm.fr.
(3)Department of Epidemiology, Biostatistic and Clinical Research, Bichat
Hospital, AP-HP, F-75018, Paris, France.
(4)INSERM, CIC-EC 1425, Bichat Hospital, AP-HP, F-75018, Paris, France.
(5)INSERM and University Paris Diderot, IAME, UMR 1137, 16 rue Henri Huchard,
F-75018, Paris, France.
(6)Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Team E13
(Bacteriology), CR7, INSERM, U1135, Sorbonne Université, F-75013, Paris, France.
(7)Bacteriology and Hygiene, AP-HP, Hôpitaux Universitaires Pitié
Salpêtrière-Charles Foix, F-75013, Paris, France.

This study aimed to assess characteristics associated with infections due to
carbapenem-resistant Enterobacteriaceae (CRE), producing (CPE) or not producing
(non-CPE) carbapenemase, among hospitalised patients in 2014-2016 in France.
Case-patients with CRE were compared to two control populations. In multivariate 
analysis comparing 160 CRE cases to 160 controls C1 (patients with a clinical
sample positive for carbapenem-susceptible Enterobacteriaceae), five
characteristics were linked to CRE: male gender (OR = 1.9; 95% CI = 1.3-3.4),
travel in Asia (OR = 10.0; 95% CI = 1.1-91.2) and hospitalisation in (OR = 2.4;
95% CI = 1.3-4.4) or out of (OR = 4.4; 95% CI = 0.8-24.1) France in the preceding
12 months, infection in the preceding 3 months (OR = 3.0; 95% CI = 1.5-5.9), and 
antibiotic receipt between admission and inclusion (OR = 1.9; 95% CI = 1.0-3.3). 
In multivariate analysis comparing 148 CRE cases to 148 controls C2 [patients
with culture-negative sample(s)], four characteristics were identified: prior
infection (OR = 3.3; 95% CI = 1.6-6.8), urine drainage (OR = 3.0; 95%
CI = 1.5-6.1) and mechanical ventilation (OR = 3.7; 95% CI = 1.1-13.0) during the
current hospitalisation, and antibiotic receipt between admission and inclusion
(OR = 6.6; 95% CI = 2.8-15.5). Univariate analyses comparing separately CPE cases
to controls (39 CPE vs C1 and 36 CPE vs C2) and non-CPE cases to controls (121
non-CPE vs C1 and 112 non-CPE vs C2), concomitantly with comparison of CPE to
non-CPE cases showed that only CPE cases were at risk of previous travel and
hospitalisation abroad. This study shows that, among CRE, risk factors are
different for CPE and non-CPE infection, and suggests that question patients
about their medical history and lifestyle should help for early identification of
patients at risk of CPE among patients with CRE.

DOI: 10.1007/s10096-018-3438-9 
PMID: 30488368  [Indexed for MEDLINE]

